Moving together to build a healthier world: advancing the social participation for health agenda at the World Health Assembly in 2024
A talk with Renu Khanna | Meaningfully engaging with communities - dos and don'ts: lessons from a ground perspective
South Asia Forum 2025
Safety 2024 – the 15th World Conference on Injury Prevention and Safety Promotion
Ensuring the collection, analysis and reporting of sex- and gender-specific health data in Australia
Hope for cluster headache community as psilocybin trial funded
Inclusion of triple single pill combination therapy for hypertension in WHO essential medicines list
Almost a day’s worth of calories hidden in fast food meal combos, study shows
Dr. Mohammad Abdul Salam
Abdul Salam is a clinical and public health researcher interested in cardiovascular disease prevention. He is particularly interested in developing, evaluating, and implementing novel low-cost pharmacological interventions. He has experience in clinical trials, systematic reviews and qualitative health research. Abdul Salam has a Master of Pharmacy (Pharmacology) from the Jawaharlal Nehru Technological University, India, and a PhD in Medicine from The University of Sydney, Australia.
Is the Hypertension Polypill the breakthrough we need for global blood pressure control?
Dr Faraidoon Haghdoost
Faraidoon is a medical doctor from Kurdistan, Iran, a research fellow in headache disorders at The George Institute for Global Health, and a conjoint lecturer at the University of New South Wales, Sydney, Australia. He is interested in studying headache disorders, especially migraine disease, contributing to growing awareness of the need for headache-specific research, and starting a headache-specific research group based on headache patients’ needs. He received his medical degree from the Isfahan University of Medical Sciences in Iran and his PhD from the University of New South Wales. Faraidoon is passionate about engaging with scientists, healthcare providers, and people with headache disorders through social media and other communication platforms.
Visit Faraidoon's website.